Paul Goodson | Head, IR |
Wenbin Jiang | President, CEO & Chairman |
Patrik Jeanmonod | CFO |
Max Masucci | Cowen and Company |
Matthew Sykes | Goldman Sachs Group |
David Westenberg | Piper Sandler & Co. |
Tejas Savant | Morgan Stanley |
Thank you for standing by, and welcome to the Cytek Biosciences First Quarter 2022 Earnings Conference Call. [Operator Instructions].
As a reminder, today's program may be recorded. And now I'd like to introduce your host for today's program, Paul Goodson, Investor Relations. Please go ahead, sir.